The Scientist

» pharmaceuticals

Most Recent

image: Spinoff Company to Develop Rare Disease Drugs

Spinoff Company to Develop Rare Disease Drugs

By | January 7, 2015

Maryland-based Vtesse will work with the US National Institutes of Health to advance treatments for Niemann-Pick Type C disease and other lysosomal storage disorders.

1 Comment

image: Merck Buys Cubist for $8.4B

Merck Buys Cubist for $8.4B

By | December 11, 2014

Hours after the pharmaceutical giant announced the acquisition, a federal judge invalidated key patents behind the antibiotic maker’s most lucrative product.

0 Comments

image: Pharma and Biotech Firms Hacked

Pharma and Biotech Firms Hacked

By | December 2, 2014

Cyberspies have broken into the e-mails of a number of publicly traded companies, most of which are in health care and pharmaceuticals.

0 Comments

image: Study: Drug Development Costs $2.6B

Study: Drug Development Costs $2.6B

By | November 24, 2014

A new estimate finds the pricetag for taking a drug through the approval process has steadily risen over the past few decades.

0 Comments

image: Push For Data Disclosure

Push For Data Disclosure

By | November 21, 2014

Two federal health agencies released proposed rules that would tighten the requirements for reporting clinical trial results.

0 Comments

image: Taking Shots at Ebola

Taking Shots at Ebola

By | November 5, 2014

With an infusion of public and private resources and accelerated regulatory processes, a handful of companies are racing to develop a vaccine to curb the Ebola epidemic.

4 Comments

image: Report: Sales for Antibiotics on Farms Rose

Report: Sales for Antibiotics on Farms Rose

By | October 6, 2014

Amid concerns that the use of antibiotics may contribute to drug resistance, sales for use in livestock rose in recent years.

0 Comments

image: AbbVie Buys Shire for $54 Billion

AbbVie Buys Shire for $54 Billion

By | July 21, 2014

The massive pharma deal will create one of the 50 largest companies in the world, and will move AbbVie’s corporate tax headquarters from North Chicago to the U.K.

0 Comments

image: Welcome Back, Pharmalot

Welcome Back, Pharmalot

By | June 4, 2014

The Wall Street Journal revives the popular blog covering pharmaceutical and biotech industry news.

0 Comments

image: Novartis and Glaxo Agree to Big Deal

Novartis and Glaxo Agree to Big Deal

By | April 22, 2014

The pharmaceutical companies announce a suite of asset swaps that drove up share prices and will reshape both.

2 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. Genetic Analysis Reveals the Evolutionary History of Dogs
  4. March for Science: Dispatches from Washington, DC
AAAS